Schedule of Equity Method Investment (Details) |
3 Months Ended |
|---|---|
|
Mar. 31, 2025
USD ($)
| |
| Equity Method Investments and Joint Ventures [Abstract] | |
| Equity method investments, balance | $ 41,763,568 |
| Portion of loss from eXoZymes | (872,518) |
| Equity method investments, balance | $ 40,891,050 |
| X | ||||||||||
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The profit or loss on sales of previously unissued stock by equity investees made to investors outside the consolidated group that is not reported as operating income. Represents the difference in the parent company's carrying amount of the equity interest in the subsidiary or equity investee immediately before and after the transaction. No definition available.
|